Literature DB >> 9223061

Relation of age and apolipoprotein E to cognitive function in Down syndrome adults.

G E Alexander1, A M Saunders, J Szczepanik, T L Strassburger, P Pietrini, A Dani, M L Furey, M J Mentis, A D Roses, S I Rapoport, M B Schapiro.   

Abstract

To test the cognitive effects of aging and apolipoprotein E (APOE) in individuals at high risk for Alzheimer's disease (AD), we assessed APOE genotypes and performance on a battery of neuropsychological tests in 41 non-demented, Down syndrome (DS) adults. Old DS subjects (ages 41-61 years) showed poorer memory and orientation scores than young DS adults (ages 22-38 years), but the groups did not differ in other measures after we controlled for intellectual function. Language ability was inversely related to APOE genotype, even after age was controlled for, with the presence of the epsilon 2 allele corresponding to better language skills than epsilon 4. Age-related cognitive changes in non-demented DS adults are consistent with the early effects of AD. The relationship between basic linguistic skills and APOE genotype supports this genetic factor in influencing the development of dementia and AD neuropathology in DS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223061     DOI: 10.1097/00001756-199705260-00009

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  7 in total

1.  Propositional density and apolipoprotein E genotype among persons at risk for familial Alzheimer's disease.

Authors:  Luis D Medina; Yaneth Rodriguez-Agudelo; Daniel H Geschwind; Paul E Gilbert; Li-Jung Liang; Jeffrey L Cummings; John M Ringman
Journal:  Dement Geriatr Cogn Disord       Date:  2011-08-30       Impact factor: 2.959

2.  Maternal Choline Supplementation Alters Basal Forebrain Cholinergic Neuron Gene Expression in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Christy M Kelley; Stephen D Ginsberg; Melissa J Alldred; Barbara J Strupp; Elliott J Mufson
Journal:  Dev Neurobiol       Date:  2019-06-09       Impact factor: 3.964

Review 3.  Exercise, APOE genotype, and the evolution of the human lifespan.

Authors:  David A Raichlen; Gene E Alexander
Journal:  Trends Neurosci       Date:  2014-03-30       Impact factor: 13.837

4.  Development and validation of the Arizona Cognitive Test Battery for Down syndrome.

Authors:  Jamie O Edgin; Gina M Mason; Melissa J Allman; George T Capone; Iser Deleon; Cheryl Maslen; Roger H Reeves; Stephanie L Sherman; Lynn Nadel
Journal:  J Neurodev Disord       Date:  2010-09-01       Impact factor: 4.025

Review 5.  A Review of Biomarkers for Alzheimer's Disease in Down Syndrome.

Authors:  Ni-Chung Lee; Yin-Hsiu Chien; Wuh-Liang Hwu
Journal:  Neurol Ther       Date:  2017-07-21

Review 6.  Psychosocial Risk Factors for Alzheimer's Disease in Patients with Down Syndrome and Their Association with Brain Changes: A Narrative Review.

Authors:  Osama Hamadelseed; Ibrahim H Elkhidir; Thomas Skutella
Journal:  Neurol Ther       Date:  2022-05-21

Review 7.  Memory profiles in Down syndrome across development: a review of memory abilities through the lifespan.

Authors:  Mary Godfrey; Nancy Raitano Lee
Journal:  J Neurodev Disord       Date:  2018-01-29       Impact factor: 4.025

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.